Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Change in Account Payables (2018 - 2025)

Exagen (XGN) has disclosed Change in Account Payables for 8 consecutive years, with $587000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables fell 74.87% year-over-year to $587000.0, compared with a TTM value of $42000.0 through Dec 2025, down 86.36%, and an annual FY2025 reading of $42000.0, down 86.36% over the prior year.
  • Change in Account Payables was $587000.0 for Q4 2025 at Exagen, down from $1.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $2.3 million in Q4 2024 and bottomed at -$1.8 million in Q2 2025.
  • Average Change in Account Payables over 5 years is $33150.0, with a median of $270500.0 recorded in 2022.
  • The sharpest move saw Change in Account Payables skyrocketed 1030.62% in 2023, then crashed 468.29% in 2024.
  • Year by year, Change in Account Payables stood at $430000.0 in 2021, then crashed by 137.21% to -$160000.0 in 2022, then surged by 1030.62% to $1.5 million in 2023, then soared by 56.88% to $2.3 million in 2024, then plummeted by 74.87% to $587000.0 in 2025.
  • Business Quant data shows Change in Account Payables for XGN at $587000.0 in Q4 2025, $1.0 million in Q3 2025, and -$1.8 million in Q2 2025.